CD4 and primary biliary cholangitis: miR-181a downregulation in CD4+ T cells promotes PBC progression by suppressing Th17 apoptosis via B-cell lymphoma-2 (BCL-2) upregulation, thereby sustaining T cell hyperactivation (36).